Cutaneous Infiltration due to Waldenström Macroglobulinemia

Actas Dermosifiliogr (Engl Ed). 2018 Jan-Feb;109(1):75-78. doi: 10.1016/j.ad.2017.04.021. Epub 2017 Aug 4.

[Article in English, Spanish]

Authors

S Oscoz-Jaime¹, A D Agulló-Pérez², C Llanos-Chavarri³, J I Yanguas-Bayona²

Affiliations

¹ Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona (Navarra), España. Electronic address: [email protected].
² Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona (Navarra), España.
³ Servicio de Anatomía Patológica, Complejo Hospitalario de Navarra, Pamplona (Navarra), España.

PMID: 28784233
DOI: 10.1016/j.ad.2017.04.021

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bendamustine Hydrochloride / administration & dosage
Disease Progression
Humans
Lymphocytes / pathology
Male
Methylprednisolone / administration & dosage
Plasma Cells / pathology
Rituximab / administration & dosage
Skin / pathology*
Waldenstrom Macroglobulinemia / drug therapy
Waldenstrom Macroglobulinemia / pathology*

Substances

Rituximab
Bendamustine Hydrochloride
Methylprednisolone